Despite Cheap and Available Drugs, Neurent Spies Opportunity in Chronic Rhinitis Market

 
• By Barnaby Pickering
  
Ireland's Neurent Medical hopes Neuromark will be a new option for patients with chronic rhinitis. (New Africa/Shutterstock)

More from Respiratory

More from Medtech Insight